These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 459604
41. [Plasmocytic pleural effusion disclosing multiple myeloma]. Elloumi M, Frikha M, Masmoudi H, Mseddi S, Ben Ayed M, Bouaziz M, Makni F, Souissi T. Rev Mal Respir; 2000 Apr; 17(2):495-7. PubMed ID: 10859769 [Abstract] [Full Text] [Related]
42. [A further case of myeloma with paraprotein showing antistreptolysin O activity (unusual visceral signs, radiological regression under treatment]. Sauvezie B, Missioux D, Leroy V, Wahl D, Goumy P, Bussière JL, Rampon S. Rev Rhum Mal Osteoartic; 1974 Jun; 41(6):449-53. PubMed ID: 4425245 [No Abstract] [Full Text] [Related]
44. Non-secretory myeloma in young man mimicking the Gorham disease: case report and the literature review. Ferjani HL, Mariem M, Affess H, Maatallah K, Kaffel D, Jenzri M, Hamdi W. Rom J Intern Med; 2022 Mar 01; 60(1):77-84. PubMed ID: 34610233 [Abstract] [Full Text] [Related]
45. [Clinical importance of the paraprotein index in multiple myeloma]. Papajík T, Bacovský J, Zadrazil J, Budíková M, Faltýnek L, Scudla V. Vnitr Lek; 1994 Aug 01; 40(8):502-5. PubMed ID: 7941436 [Abstract] [Full Text] [Related]
46. The laboratory diagnosis of plasma cell myeloma and related disorders. Nawab RA, Azar HA. Orthop Clin North Am; 1979 Apr 01; 10(2):391-404. PubMed ID: 109804 [Abstract] [Full Text] [Related]
47. Myeloma cell resistance to melphalan, BCNU and epirubicin determined in vitro with the 3H-thymidine incorporation technique prior to chemotherapy. Gola A, Kuliczkowski K, Sedek K. Neoplasma; 1992 Apr 01; 39(1):35-8. PubMed ID: 1528303 [Abstract] [Full Text] [Related]
48. Monitoring myeloma: light chain isotype suppression. A new parameter. Wearne A, Joshua DE, Kronenberg H. Aust N Z J Med; 1985 Oct 01; 15(5):629-33. PubMed ID: 3937514 [Abstract] [Full Text] [Related]
49. [A case of Bence-Jones protein-lambda positive multiple myeloma complicated by abnormal plasma cells in pleural effusion]. Shirai T, Hashizume I, Kasamatsu N, Nakamura A, Yamatani H, Hanzawa S, Momiki S, Sasaki K, Yano K, Ozawa T. Nihon Kokyuki Gakkai Zasshi; 1998 Feb 01; 36(2):176-81. PubMed ID: 9617146 [Abstract] [Full Text] [Related]
50. Neoplasms of terminally differentiated B lymphocytes. Holbert JM. Clin Lab Med; 1988 Mar 01; 8(1):197-210. PubMed ID: 3282759 [Abstract] [Full Text] [Related]
51. [Non-secretory myeloma syndrome]. Pinto F, Santonastaso M, Dannhäuser D, Borsato N, Todeschini G. Recenti Prog Med; 2001 Sep 01; 92(9):533-6. PubMed ID: 11552309 [Abstract] [Full Text] [Related]
52. [Isotypic characterization of IgA paraproteins: association with other clinical and analytic data]. González González JB, García Delgado R, Cámara Sáez E, Ortiz Maslloréns F. Rev Clin Esp; 1996 Aug 01; 196(8):529-35. PubMed ID: 8984539 [Abstract] [Full Text] [Related]
53. Intracytoplasmic and surface-bound immunoglobulins in "nonsecretory" and Bence-Jones myeloma. Preud'Homme JL, Hurez D, Danon F, Brouet JC, Seligmann M. Clin Exp Immunol; 1976 Sep 01; 25(3):428-36. PubMed ID: 822974 [Abstract] [Full Text] [Related]
57. The spectrum of neurological manifestations in myeloma. Camacho J, Arnalich F, Anciones B, Peña JM, Gil A, Barbado FJ, Puig JG, Vazquez JJ. J Med; 1985 Sep 01; 16(5-6):597-611. PubMed ID: 3868689 [Abstract] [Full Text] [Related]
58. Biclonal gammopathy in multiple myeloma: a case report. Bakta IM, Sutarka IN. Gan To Kagaku Ryoho; 2000 May 01; 27 Suppl 2():544-8. PubMed ID: 10895208 [Abstract] [Full Text] [Related]
59. [Nonproducing myeloma without evident bone lesion]. Kawatani T, Maeda N, Hosoda A, Agou H, Nakai K, Kawasaki H. Rinsho Ketsueki; 1990 Jun 01; 31(6):842-6. PubMed ID: 2214175 [Abstract] [Full Text] [Related]